Outcomes after Discontinuing Tumor Necrosis Factor Inhibitor in Rheumatoid Arthritis: 2 Years of 'post-Golimumab' after Completion of the 5-Tear Extension Study in Korea
배상철
제목
Outcomes after Discontinuing Tumor Necrosis Factor Inhibitor in Rheumatoid Arthritis: 2 Years of 'post-Golimumab' after Completion of the 5-Tear Extension Study in Korea